Alicon Castalloy Ltd
ALICONAlicon Castalloy Ltd's three tracks disagree. Price, valuation and the earnings engine each tell a different story — the next quarter or two settles it.
The sharpest disagreement: Domestic institutions moved +1.5 points over 8 quarters while the operating story went the other way — someone close to the numbers is not convinced.
The price is in a downtrend (33 weeks in) while the P/E sits at the 68th percentile of its own 10-year range. Underneath, the last four quarters read deteriorating — profit −15.8% year on year, and 426% of the last 3 years' profit arrived as cash. What settles it: whether the register turns back in the story’s favour.
Price story Before the numbers, the tape. A stock price moves through four repeating seasons: a flat base (stage 1), an advance (2), a top (3), a decline (4). Where the price sits in that cycle frames everything below.
Alicon Castalloy Ltd trades at ₹672, in a downtrend and 33 weeks into that stage. That is −7.6% against its own 200-day average. It sits at 16% of a 52-week range of ₹622 to ₹929. On relative strength it is currently behind the NIFTY 500 on a trailing-13-week view (16 weeks and counting).
Today the stock is in a downtrend — week 33 of stage 4, confirmed. At ₹672 it trades −7.6% versus its 200-day average and sits at 16% of its 52-week range (₹622–₹929).
Against the market, two honest reads. Cumulative: over the last 10.4 years the stock moved +154% while the NIFTY 500 moved +276% — behind the index over the full window. Recent form: on a trailing-13-week view the stock is currently behind (16 weeks and counting; last ahead the week of 2026-05-15) — the ribbon below is that same metric, week by week.
What would end the trend, mechanically: two Friday closes in a row below the 200-day line. That is the exit rule — no debates.
Valuation P/E is the price of ₹1 of annual profit: how many rupees the market pays for each rupee the company earns in a year.
Alicon Castalloy Ltd trades at 28.1× P/E, mid-range by its own standards (68th percentile). Its long-run median P/E is 25.3×, measured across 10.4 years of weekly readings. This places the multiple against the stock’s own record, and says nothing about what the business is worth.
Today's P/E of 28.1× is mid-range by its own standards (68th percentile), against a long-run median of 25.3× measured over 10.4 years of weekly readings. This is a comparison against the stock's own history — not a claim about what it is worth.
Why the multiple sits where it does: over the past year annual EPS moved −25.6% against a −25.2% price move — the price outran earnings, pushing the multiple UP its own range.
The price move, decomposed: over 5y, of the −3.3%/yr price move, ~−2.7%/yr came from earnings growth and ~−0.6 pp from the multiple (roughly flat); over 10y, of the +8.6%/yr price move, ~+2.5%/yr came from earnings growth and ~+6.1 pp from the multiple (expanding). The split is the honest approximate (price return minus earnings growth); it makes the rally itself visible instead of hiding it behind the percentile.
Put together: the multiple is full against its own past, so the story rests on the earnings line underneath it, not the multiple.
A quarterly PEG curve, which only the second data source carries, is not drawn on this page: its two data sources do not share enough overlapping reported history to be compared. A figure nobody could check is not used to price growth — the gap is a decision, not missing data.
Stage: Mixed Every business sits somewhere on a fundamental arc, and this page names the spot before anything else. The last twelve quarters of revenue, profit and EPS growth — plus the return the business earns on its capital — are read as curves: Deteriorating (the curves are falling), Turning around (a trough has just formed and the last few quarters lift off it), Improving (the climb off the trough is sustained), Consistent (steadily positive with healthy returns), Topping out (still high but decelerating from the peak). When the curves genuinely disagree the read is Mixed; too little history is No read. CAGR (compound annual growth rate) is the smooth yearly pace that turns the starting value into the latest one — the fairest way to compare growth across different time spans. Read the columns together: if the 1-year number towers over the 10-year, recent growth is running hotter than the long-run trend. A dash means that window is not held, or the base year was a loss (where a growth rate is not meaningful).
Alicon Castalloy Ltd reads as mixed on its fundamental arc. Mixed — no clean majority across the growth curves, ROCE holding at 10.0% — the per-curve reads carry the story. The read is built from 10 quarters across 3 curves, on partial evidence.
Why it matters: when the curves disagree, the per-curve reads above matter more than any single verdict.
One or more growth curves carry a base-effect spike — a large year-on-year move off a near-zero or loss-making comparable quarter. Those spikes are capped before the classifier reads the trajectory, and shown pinned on the chart, so a single distorted quarter does not drive the stage call.
Return readings here are annual, not quarterly — read as level and direction only; they can confirm the growth curves but never drive the stage on their own.
A partial read: at least one curve is short, or the returns curve is not the computed quarterly series — hold the stage word a little more loosely.
| 1yr | 3yr | 5yr | 10yr | |
|---|---|---|---|---|
| Revenue | +3.3% | +8.2% | +15.9% | +9.0% |
| Profit | −26.1% | −12.6% | — | +4.4% |
| EPS | −25.6% | −12.9% | — | +1.5% |
| Share price | −25.2% | −6.5% | −3.3% | +8.6% |
4-Factor Sector Score
35.2/100 — rank 16 of 19 in Castings, Forgings & Fastners · 77% evidence confidence
Alicon Castalloy Ltd scores 35.2 out of 100 against the 19 companies it is compared with in Castings, Forgings & Fastners, ranking 16. Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
The four contributions add to the total exactly: 9.7 + 10.1 + 10.9 + 4.5 = 35.2. This is the SAME number shown on the sector comparison — it is computed once, for the whole peer set, and read here.
What would change it: The read weakens if profit growth turns negative or margin improvement reverses while sector-relative strength deteriorates.
Revenue Revenue is the top line: everything the company billed its customers in the period.
Alicon Castalloy Ltd reported ₹495 Cr of revenue in the Mar 26 quarter, +16.6% year on year. That is the 2nd straight quarter of year-on-year growth. Over 10 years it has compounded at 9.0% a year. The last full year, FY26, came in at ₹1,776 Cr. The last four reported quarters add to ₹1,771 Cr.
FY26 revenue came in at ₹1,776 Cr (+3.3% on the year), capping 10 years at 9.0% compound. The latest quarter (Mar 26) printed ₹495 Cr, +16.6% year on year — the 2nd consecutive quarter of year-over-year growth.
Pace check: the last four quarters averaged +3.4% growth against the decade's 9.0% — the current year is running slower than its own long-run rate.
Acceleration check: trailing-twelve-month revenue grew +3.0% over the last 4 quarters against +6.6%/yr over the last 8 — rolling over; TTM profit −25.2% vs −25.0%/yr — stabilising.
Operating margin Operating margin is what is left of every ₹100 of sales after running the business, before interest and tax. It is the cleanest read on pricing power and cost control.
Alicon Castalloy Ltd's operating margin is 9.2% in the Mar 26 quarter, −1.8 percentage points against the same quarter a year ago. Across 13 fiscal years the operating margin has ranged 10.0% to 13.0%. The current quarter is running below every full year in that window.
The latest quarter's operating margin is 9.2%, −1.8 pp against the same quarter a year ago. Across 13 fiscal years the operating margin has ranged 10.0%–13.0%.
🚨 Why the margin moved: operating margin went −1.8 pp year on year while gross margin went −2.5 pp — the loss came mostly from the gross line: input costs and pricing.
Net profit Net profit is what survives every cost, interest and tax — the number EPS, dividends and book value all grow from.
Alicon Castalloy Ltd earned ₹7.9 Cr of net profit in the Mar 26 quarter, −15.8% year on year. Full-year FY26 profit was ₹34.0 Cr. The 10-year compound rate is 4.4%. That is 1.6% of the quarter's revenue. The same quarter a year earlier earned ₹9.4 Cr.
Mar 26 profit was ₹7.9 Cr, −15.8% year on year. On the full year, FY26 printed ₹34.0 Cr (−26.1%), and the 10-year compound rate is 4.4%.
🚨 Why profit moved: revenue contributed +16.6% and the margin −1.8 pp — the quarter was revenue-led, with the margin roughly flat.
Pace comparison, last four quarters: profit +59.7% vs revenue +3.4%. Profit is growing faster than sales — fixed costs are being spread over a bigger base, and each extra rupee of revenue drops more to the bottom line.
Cash flow — the router The P&L says what was earned; the cash-flow statement says what actually arrived. Operating cash flow (CFO) against profit is the cleanest lie detector in the accounts.
Over the last 3 fiscal years 426% of Alicon Castalloy Ltd's reported profit arrived as operating cash — the cash follows the profit. In FY26 that was ₹239 Cr of operating cash against ₹34.0 Cr of profit. After ₹164 Cr of capital spending, ₹75.0 Cr was left as free cash.
FY26: operating cash of ₹239 Cr against reported profit of ₹34.0 Cr, leaving free cash of ₹75.0 Cr after ₹164 Cr of capital spending. Across the last 3 fiscal years the conversion rate is 426% of profit.
Cash-flow readings here are annual — that is the resolution our series carries, so this section moves once a year.
Why conversion sits at 426%: the cash cycle tightened 73 days between FY21 and FY26 — cash that used to wait in the cycle now reaches the bank sooner.
Router verdict: the bigger cash user is investment — capital spending ran 1.8× depreciation over three years, so the next section's job is to check what that build-out is buying.
Where the cash goes Working capital is the cash tied up between paying suppliers and getting paid: debtor days (customers owe), inventory days (stock waits), and the cash conversion cycle (the whole loop, in days of sales).
Alicon Castalloy Ltd's cash conversion cycle runs 37 days in FY26, down from 110 days in FY21. Capital spending ran ₹489 Cr over the last 3 years. At FY26 sales of ₹1,776 Cr each day of that cycle holds about ₹4.9 Cr, so roughly ₹180 Cr sits inside the business at any moment.
FY26: debtors at 110 days, inventory at 62 days — roughly 2.0 months of stock waiting to sell; that is where the cash sits while it waits — for a full cycle of 37 days, tighter than FY21's 110.
The full loop: cash goes out to suppliers and production on day 0; stock waits 62 days to sell; customers pay about 110 days after that; and suppliers themselves are paid at 135 days — netting out to the 37-day cycle.
In money terms: at FY26 sales of ₹1,776 Cr, each day of the cycle holds about ₹4.9 Cr — so the 37-day loop keeps roughly ₹180 Cr sitting inside the business at any moment.
On the investment side: capital spending of ₹489 Cr over the last 3 fiscal years against ₹275 Cr of depreciation — the company is building well ahead of wear-and-tear. Capital work-in-progress stands at ₹58.0 Cr (FY26) — capacity paid for but not yet earning.
The synthesis: the cash is going into capacity, not disappearing into the cycle — the question becomes whether the new capacity earns.
Return on capital Return on capital employed (ROCE) is the profit the whole business earns on all the money in it — equity and debt together. It is the single best test of whether growth creates value or just size.⚠ unverified
Alicon Castalloy Ltd earns a ROCE of 10% in FY26. That is up from a trough of 6% in FY21. Return on invested capital clears the cost of that capital by −4.6 percentage points, so growth here is not yet paying for the capital it uses. The wiring behind it is 1.9% net margin on 1.23× asset turns.
FY26 ROCE is 10%, recovered from a FY21 trough of 6% — the full ladder below shows the fall and the climb, undoctored.
🚨 Why the return is what it is — the wiring (FY26): 1.9% net margin × 1.23× asset turns × 2.30× balance-sheet leverage ≈ 5.4% on equity. Margin does its share; leverage is a meaningful part of the equation.
The capstone test — ROIC − WACC: 7.4% − 12.0% = a −4.6 pp spread. The 12.0% is a standing assumption for the cost of capital in India, not a per-stock estimate — read the sign and the size of the spread, not the decimals. Negative — growth at these returns destroys value until the returns recover.
Debt Debt-to-equity says how much of the business is funded by borrowings. Low is the safe corner; the trend matters as much as the level.⚠ unverified
Alicon Castalloy Ltd carries total debt of ₹354 Cr against shareholder equity of ₹628 Cr as of Mar 26, a debt-to-equity of 0.56. On the annual view that ratio went from 0.59 in FY22 to 0.56 in FY26. Read the returns elsewhere on this page with that leverage in mind.
Mar 26: total debt of ₹354 Cr against shareholder equity of ₹628 Cr — a debt-to-equity of 0.56. On the annual view, debt-to-equity went from 0.59 (FY22) to 0.56 (FY26). Read the returns on this page with that leverage in mind.
Ownership Who owns the stock, quarter by quarter: promoters (the controlling owners), foreign and domestic institutions, and the public. Steady accumulation by people close to the numbers is a signal; a quiet register is also an answer.
Domestic institutions added 1.5 points of Alicon Castalloy Ltd over 8 quarters, the biggest move on the register. That takes domestic institutions to 10.6% of the company. Promoters moved −1.4 points over the same window, to 53.8%. The register is read on the four disclosed classes only; nothing is inferred between filings.
The register over the last two years — Domestic institutions: +1.5 points over 8 quarters to 10.6%; Promoters: −1.4 points over 8 quarters to 53.8%; Foreign institutions: −0.6 points over 8 quarters to 0.2%.
Why the register moved: domestic institutions drove it (+1.5 points), absorbed on the other side by promoters (−1.4 points) — steady accumulation by institutions reading the same numbers this page reads.
Safety line The Z-score estimates how far a company sits from balance-sheet distress — above roughly 3 is safe, below roughly 1.8 is the danger zone. It was built for manufacturers, so it is not applied to banks and lenders.
Alicon Castalloy Ltd: the Z-score is not available for this stock, so we say so rather than invent one. It is a distance-to-distress estimate from the balance sheet, not a forecast of failure. The debt, cash-flow and return sections above carry the balance-sheet evidence this page does hold, and each of them states its own reporting date.
The safety line in one sentence: the Z-score is not available for this stock, so we say so rather than invent one.
| Company | Score | Price stage | Growth & earnings/35 | Capital efficiency/25 | Valuation/20 | Relative strength/20 |
|---|---|---|---|---|---|---|
| 1Uniparts India LtdUNIPARTS | 80.2/100Sector-leading setup96% evidence | LEADER | 31.1/35 Revenue 21.6% · PAT 78.4% · OPM change 10 pp 88% evidence | 17.5/25 ROCE 21.6% · OPM 24% 100% evidence | 13.4/20 P/E 20.4× · PEG 0.38 100% evidence | 18.2/20 RS sector 19.9% · RS bench 41.7% · 1Y 96.5%12 of 12 weeks ahead 100% evidence |
| Exact sum: 31.1 + 17.5 + 13.4 + 18.2 = 80.2 · Decision use: Confirmed research leader: earnings, capital efficiency and relative strength agree. Move to management, catalyst and risk diligence. | ||||||
| 2Uni Abex Alloy Products Ltd504605 | 67.3/100Favorable setup78% evidence | LEADER | 22.1/35 Revenue 13.5% · PAT 100% · OPM change 5 pp 83% evidence | 18.0/25 ROCE 19.2% · OPM 31% 76% evidence | 10.1/20 P/E 19.8× · PEG — 50% evidence | 17.1/20 RS sector 13.8% · RS bench 34.4% · 1Y 36.9%12 of 12 weeks ahead 100% evidence |
| Exact sum: 22.1 + 18 + 10.1 + 17.1 = 67.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 3Gala Precision Engineering LtdGALAPREC | 67.3/100Favorable setup76% evidence | LEADER | 27.1/35 Revenue 32.5% · PAT 34.6% · OPM change 1 pp 83% evidence | 14.2/25 ROCE 15.6% · OPM 18% 95% evidence | 9.8/20 P/E 38.6× · PEG — 15% evidence | 16.2/20 RS sector 9.3% · RS bench 29.4% · 1Y 27.8%12 of 12 weeks ahead 100% evidence |
| Exact sum: 27.1 + 14.2 + 9.8 + 16.2 = 67.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 4Sona BLW Precision Forgings LtdSONACOMS | 60.4/100Mixed-positive evidence97% evidence | LEADER | 22.8/35 Revenue 39.6% · PAT 18.1% · OPM change -1 pp 95% evidence | 12.3/25 ROCE 14.2% · OPM 23% 95% evidence | 6.8/20 P/E 65.9× · PEG 3.04 100% evidence | 18.5/20 RS sector 21.8% · RS bench 44.1% · 1Y 63.9%12 of 12 weeks ahead 100% evidence |
| Exact sum: 22.8 + 12.3 + 6.8 + 18.5 = 60.4 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 5Happy Forgings LtdHAPPYFORGE | 58.4/100Mixed-positive evidence96% evidence | LEADER | 20.0/35 Revenue 9.8% · PAT 12.7% · OPM change 2 pp 88% evidence | 16.6/25 ROCE 18% · OPM 31% 100% evidence | 6.1/20 P/E 52.2× · PEG 1.69 100% evidence | 15.7/20 RS sector 15.6% · RS bench 36.4% · 1Y 72%8 of 12 weeks ahead 100% evidence |
| Exact sum: 20 + 16.6 + 6.1 + 15.7 = 58.4 · Decision use: Strong business, demanding price: keep it on the quality list, but require either earnings upgrades or valuation compression. | ||||||
| 6Amic Forging Ltd544037 | 56.9/100Thin evidence · provisional58% evidence | LEADER | 17.8/35 Revenue — · PAT — · OPM change 5 pp 26% evidence | 20.2/25 ROCE 23.5% · OPM 33% 76% evidence | 7.6/20 P/E 72.9× · PEG — 50% evidence | 11.3/20 RS sector -2.1% · RS bench 16.4% · 1Y 18.1%12 of 12 weeks ahead 100% evidence |
| Exact sum: 17.8 + 20.2 + 7.6 + 11.3 = 56.9 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 7Balu Forge Industries LtdBALUFORGE | 56.6/100Mixed-positive evidence90% evidence | ASLEEP | 17.3/35 Revenue 19.9% · PAT 27% · OPM change -5 pp 88% evidence | 20.6/25 ROCE 22.7% · OPM 23% 100% evidence | 15.4/20 P/E 20.6× · PEG 1.46 100% evidence | 3.3/20 RS sector -27.9% · RS bench -18.5% · 1Y -29.5%0 of 10 weeks ahead 70% evidence |
| Exact sum: 17.3 + 20.6 + 15.4 + 3.3 = 56.6 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 8Bharat Forge LtdBHARATFORG | 56.1/100Mixed-positive evidence71% evidence | BREAKING OUT | 21.1/35 Revenue 11.2% · PAT 19.1% · OPM change -1 pp 83% evidence | 12.6/25 ROCE 12.6% · OPM 17% 76% evidence | 9.0/20 P/E 93.2× · PEG — 15% evidence | 13.4/20 RS sector 13.8% · RS bench 34.1% · 1Y 82.7%10 of 12 weeks ahead 100% evidence |
| Exact sum: 21.1 + 12.6 + 9 + 13.4 = 56.1 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 9Steelcast LtdSTEELCAS | 55.0/100Mixed-positive evidence100% evidence | LEADER | 16.8/35 Revenue 9.2% · PAT 15.2% · OPM change 0 pp 100% evidence | 18.9/25 ROCE 32.3% · OPM 26% 100% evidence | 8.6/20 P/E 34.6× · PEG 1.7 100% evidence | 10.7/20 RS sector 6.5% · RS bench 25.9% · 1Y 32.7%10 of 12 weeks ahead 100% evidence |
| Exact sum: 16.8 + 18.9 + 8.6 + 10.7 = 55 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 10Kennametal India LtdKENNAMET | 54.7/100Mixed-positive evidence96% evidence | FADING | 19.5/35 Revenue 10.2% · PAT -4.3% · OPM change 2.1 pp 88% evidence | 16.9/25 ROCE 24.6% · OPM 16.1% 100% evidence | 10.3/20 P/E 53× · PEG 1.53 100% evidence | 8.0/20 RS sector -1.3% · RS bench 16.8% · 1Y 23%11 of 12 weeks ahead 100% evidence |
| Exact sum: 19.5 + 16.9 + 10.3 + 8 = 54.7 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 11Tirupati Forge LtdTIRUPATIFL | 50.9/100Mixed-positive evidence76% evidence | BREAKING OUT | 14.0/35 Revenue 41.3% · PAT -19.9% · OPM change -2.1 pp 83% evidence | 8.2/25 ROCE 7.5% · OPM 9.2% 95% evidence | 8.7/20 P/E 144× · PEG — 15% evidence | 20.0/20 RS sector 38.5% · RS bench 63% · 1Y 75.8%10 of 12 weeks ahead 100% evidence |
| Exact sum: 14 + 8.2 + 8.7 + 20 = 50.9 · Decision use: Price leads the evidence: RS versus the benchmark is 63%, but earnings trajectory is weak. Wait for revenue and profit confirmation. | ||||||
| 12M M Forgings LtdMMFL | 47.9/100Mixed-negative evidence96% evidence | BREAKING OUT | 12.1/35 Revenue 4.3% · PAT -18.9% · OPM change -1 pp 88% evidence | 10.6/25 ROCE 9% · OPM 19% 100% evidence | 12.9/20 P/E 26.9× · PEG 0.66 100% evidence | 12.3/20 RS sector 13.1% · RS bench 33.7% · 1Y 51.7%5 of 12 weeks ahead 100% evidence |
| Exact sum: 12.1 + 10.6 + 12.9 + 12.3 = 47.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 13CIE Automotive India LtdCIEINDIA | 45.4/100Mixed-negative evidence100% evidence | ASLEEP | 19.2/35 Revenue 12.5% · PAT 14.3% · OPM change 1 pp 100% evidence | 14.3/25 ROCE 14.7% · OPM 15% 100% evidence | 10.1/20 P/E 17.3× · PEG 2.4 100% evidence | 1.8/20 RS sector -22.6% · RS bench -7.6% · 1Y -1.2%0 of 12 weeks ahead 100% evidence |
| Exact sum: 19.2 + 14.3 + 10.1 + 1.8 = 45.4 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 14Nelcast LtdNELCAST | 41.7/100Mixed-negative evidence87% evidence | ASLEEP | 15.3/35 Revenue 4.2% · PAT -1.8% · OPM change -3.9 pp 95% evidence | 12.3/25 ROCE 11.4% · OPM 4.6% 95% evidence | 11.8/20 P/E 25.7× · PEG — 50% evidence | 2.3/20 RS sector -20.7% · RS bench -5.6% · 1Y -23.2%7 of 12 weeks ahead 100% evidence |
| Exact sum: 15.3 + 12.3 + 11.8 + 2.3 = 41.7 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 15Ramkrishna Forgings LtdRKFORGE | 40.7/100Mixed-negative evidence75% evidence | BREAKING OUT | 14.8/35 Revenue 8.6% · PAT -71.3% · OPM change 4 pp 95% evidence | 7.3/25 ROCE 5.6% · OPM 18% 76% evidence | 8.8/20 P/E 103× · PEG — 15% evidence | 9.8/20 RS sector -2.6% · RS bench 16.3% · 1Y 4.2%3 of 12 weeks ahead 100% evidence |
| Exact sum: 14.8 + 7.3 + 8.8 + 9.8 = 40.7 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 16Alicon Castalloy Ltdthis pageALICON | 35.2/100Mixed-negative evidence77% evidence | ASLEEP | 9.7/35 Revenue 3% · PAT -25.2% · OPM change -1.8 pp 83% evidence | 10.1/25 ROCE 10% · OPM 9.2% 95% evidence | 10.9/20 P/E 28.1× · PEG — 50% evidence | 4.5/20 RS sector -20.7% · RS bench -12.7% · 1Y -27%0 of 10 weeks ahead 70% evidence |
| Exact sum: 9.7 + 10.1 + 10.9 + 4.5 = 35.2 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 17Synergy Green Industries LtdSGIL | 27.1/100Adverse evidence76% evidence | BREAKING OUT | 4.2/35 Revenue 1.1% · PAT -72.4% · OPM change -6.5 pp 83% evidence | 7.4/25 ROCE 9.2% · OPM 8.8% 95% evidence | 8.5/20 P/E 188× · PEG — 15% evidence | 7.0/20 RS sector -8.2% · RS bench 9.6% · 1Y 8.6%9 of 12 weeks ahead 100% evidence |
| Exact sum: 4.2 + 7.4 + 8.5 + 7 = 27.1 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 18Sterling Tools LtdSTERTOOLS | 25.6/100Adverse evidence77% evidence | TURNING | 6.2/35 Revenue -19.3% · PAT -49.7% · OPM change -5.7 pp 83% evidence | 8.0/25 ROCE 7.2% · OPM 3.6% 95% evidence | 7.4/20 P/E 38.1× · PEG — 50% evidence | 4.0/20 RS sector -42.6% · RS bench -4.5% · 1Y -29.5%5 of 10 weeks ahead 70% evidence |
| Exact sum: 6.2 + 8 + 7.4 + 4 = 25.6 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 19Sundaram Clayton LtdSUNCLAY | 24.3/100Adverse evidence74% evidence | ASLEEP | 10.4/35 Revenue -3.9% · PAT 100% · OPM change -1.2 pp 74% evidence | 0.3/25 ROCE -3.3% · OPM 2% 100% evidence | 11.5/20 P/E 11× · PEG — 15% evidence | 2.1/20 RS sector -26.6% · RS bench -12% · 1Y -35.8%1 of 12 weeks ahead 100% evidence |
| Exact sum: 10.4 + 0.3 + 11.5 + 2.1 = 24.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
Missing observations are not scored as bad. Their missing weight lowers confidence and pulls the final score toward neutral. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led NIFTY 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step curve the sector itself is placed on — basing, turning, breaking out, leader, fading, asleep — read from how many weeks running it has led NIFTY 500 and whether that lead is widening or shrinking. It describes where the PRICE stands, not the earnings trajectory and not a recommendation, and it is left blank for a company whose weekly history is too short or too stale to read.
Frequently asked questions
What is Alicon Castalloy Ltd's share price today?
Alicon Castalloy Ltd trades at ₹672, −25.2% over the past year. The company is valued at ₹1,103 Cr. The stock sits at 16% of its 52-week range of ₹622–₹929, −7.6% versus its 200-day average. On the tape, the price is in a downtrend, 33 weeks in. — as of 31 July 2026.
What were Alicon Castalloy Ltd's latest quarterly results?
Alicon Castalloy Ltd reported revenue of ₹495 Cr and net profit of ₹7.9 Cr for the Mar 26 quarter. Revenue rose 16.6% and profit fell 15.8% year on year. Earnings per share were ₹4.86. The operating margin was 9.2%, 1.8 pp lower than a year earlier. — as of 31 July 2026.
What is Alicon Castalloy Ltd's revenue?
Alicon Castalloy Ltd reported revenue of ₹495 Cr in the Mar 26 quarter, +16.6% year on year. For the full FY26 fiscal year, revenue was ₹1,776 Cr (+3.3%). Over the last 10 years revenue compounded at 9.0% a year. — as of 31 July 2026.
What is Alicon Castalloy Ltd's profit?
Alicon Castalloy Ltd earned ₹7.9 Cr of net profit in the Mar 26 quarter, −15.8% year on year. Full-year FY26 profit was ₹34.0 Cr. The operating margin ran 9.2% in the latest quarter. — as of 31 July 2026.
What is Alicon Castalloy Ltd's market cap?
Alicon Castalloy Ltd's market capitalisation is ₹1,103 Cr at a share price of ₹672. Market cap is the share price multiplied by shares outstanding, so it is restated whenever the price moves. — as of 31 July 2026.
What is Alicon Castalloy Ltd's P/E ratio?
Alicon Castalloy Ltd trades at a P/E of 28.1×, at the 68th percentile of its own 10-year range, against a long-run median of 25.3×. This is a comparison with the stock's own history, not a value call — as of 31 July 2026.
Does Alicon Castalloy Ltd pay a dividend?
Yes — Alicon Castalloy Ltd's dividend payout was 9% of profit in FY26, and it recorded a payout in 12 of its last 13 reported fiscal years. This page holds the payout ratio, not a per-share amount. — as of 31 July 2026.
Is Alicon Castalloy Ltd overvalued?
On its own history, Alicon Castalloy Ltd looks expensive against its own history: its P/E of 28.1× sits at the 68th percentile of its 10-year range (long-run median 25.3×). That is a percentile read against the stock's own past, not a price opinion or a direction call. — as of 31 July 2026.
Is Alicon Castalloy Ltd growing?
Not right now — Alicon Castalloy Ltd's latest numbers are shrinking: latest-quarter revenue +16.6% year on year, profit −15.8%, and the margin −1.8 pp at 9.2%. The 10-year compound rates are 9.0% (revenue) and 4.4% (profit). The earnings engine currently reads: deteriorating — as of 31 July 2026.
How is Alicon Castalloy Ltd performing?
Alicon Castalloy Ltd is in a downtrend, 33 weeks in. Its latest quarter's revenue rose 16.6% and profit fell 15.8% year on year. Against the NIFTY 500 it has been behind on a trailing-13-week view for 16 weeks. This describes what the data did, not a rating. — as of 31 July 2026.
What stage is Alicon Castalloy Ltd in?
Mixed — no clean majority across the growth curves, ROCE holding at 10.0% — the per-curve reads carry the story. The read comes from the last 12 quarters of growth (revenue growth +16.6% latest, profit growth −15.8% latest) plus the ROCE curve, classified by deterministic rules — a trajectory read, not a buy or sell call — as of 31 July 2026.
Is Alicon Castalloy Ltd in an uptrend?
No — the price is in a downtrend (week 33 of stage 4), trading −7.6% versus its 200-day average and at 16% of its 52-week range. Price stages cycle base → advance → top → decline, and the stage names where this stock sits in that cycle — as of 31 July 2026.
Is Alicon Castalloy Ltd beating the market?
Not lately — on a trailing-13-week view Alicon Castalloy Ltd is currently behind the NIFTY 500 (16 weeks and counting; last ahead the week of 2026-05-15), the same metric the week-by-week ribbon on this page draws. Separately, on the cumulative view: over the last 10.4 years the stock moved +154% against the NIFTY 500's +276% — behind the index over the full window. — as of 31 July 2026.
Will Alicon Castalloy Ltd's share price go up?
This page publishes no price forecast for Alicon Castalloy Ltd. What it measures instead: the share price is ₹672, the price is in a downtrend 33 weeks in. Its P/E of 28.1× sits at the 68th percentile of its own 10-year range. — as of 31 July 2026.
Who owns Alicon Castalloy Ltd?
Promoters hold 53.8% of Alicon Castalloy Ltd, foreign institutions 0.2%, domestic institutions 10.6% and the public 35.4% (latest quarter). The biggest move on the register over the last two years: Domestic institutions added 1.5 points over 8 quarters. — as of 31 July 2026.
Does Alicon Castalloy Ltd have too much debt?
It is moderate — Alicon Castalloy Ltd's debt-to-equity is 0.56, and operating profit covers the interest bill 5×. FY26 borrowings were ₹354 Cr against equity of ₹628 Cr. Read the returns on this page with that leverage in mind — as of 31 July 2026.
What is Alicon Castalloy Ltd's capex?
Alicon Castalloy Ltd spent ₹489 Cr on capital expenditure over the last 3 fiscal years, a figure derived from the change in fixed assets plus depreciation. In FY26 alone that was ₹164 Cr, with ₹58.0 Cr in capital work-in-progress — capacity paid for but not yet earning. — as of 31 July 2026.
What is Alicon Castalloy Ltd's cash flow?
Alicon Castalloy Ltd generated ₹239 Cr of operating cash flow in FY26 and ₹75.0 Cr of free cash flow after ₹164 Cr of capital spending. Reported profit that year was ₹34.0 Cr, so operating cash ran ahead of profit. Cash-flow resolution for India is annual. — as of 31 July 2026.
Is Alicon Castalloy Ltd's profit real cash?
Yes — over the last 3 fiscal years, 426% of Alicon Castalloy Ltd's reported profit arrived as operating cash. In FY26, operating cash was ₹239 Cr against reported profit of ₹34.0 Cr. The cash then goes mostly into building capacity. Cash-flow resolution is annual — as of 31 July 2026.
Where is Alicon Castalloy Ltd in its business cycle?
Alicon Castalloy Ltd's FY26 operating margin was 11.0%, against a 13-year band of 10.0%–13.0%: mid-band by its own history — neither the peak that precedes mean-reversion nor the trough that precedes recovery. The latest quarter ran 9.2%. Profitability versus a company's own long band is the cleanest cycle clock this page holds — as of 31 July 2026.
What could break the Alicon Castalloy Ltd story?
The sharpest disagreement: Domestic institutions moved +1.5 points over 8 quarters while the operating story went the other way — someone close to the numbers is not convinced. Mechanically, two Friday closes in a row below the 200-day average would end the price trend — that is the exit rule this page tracks — as of 31 July 2026.
Is Alicon Castalloy Ltd a stock worth studying right now?
This is not investment advice. The machine read: Alicon Castalloy Ltd's three tracks disagree. Price, valuation and the earnings engine each tell a different story — the next quarter or two settles it. The sharpest open question: whether the register turns back in the story’s favour. Every number on this page is drawn deterministically from the raw series, with no forecasts and no price opinions — as of 31 July 2026.